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ABSTRACT: Bacopa Monnieri (L) penn. Belongs to the family scrophulariaceae is commonly 
used in Ayurvedic system of medicine to treat various disease.  The present stud examines the 
anti-tumous effect of ethanolic extract of whole plant bacopa monnieri (L) (EEMB) by in vitro 
short term chemosensitivity and in vivo tumous model test systems. EEBM dose dependently 
inhibited the proliferation of transformed cell lines significantly. Fifty percent dose on 3 hour 
exposure to EEBM was 150 µg/ml for Dalton’s lymphoma ascites tumour cells (Dla). Oral 
administration of the EEBM retarded the development of solid tumour and restored the altered 
hematological parameters near to normal. 
 
INTRODUCTION 
 
Bacopa monnieri (L) penn.syni Herpestis 
monnieria (L) .B. & K. named in various 
Indian lauguages as Brahmi, Jal Neem, Nir 
Brahmi, Sarasvati, sambarani chetty is small 
prostate herb belonging to t family 
scrophulariaceae. Grows wild I damp places 
and marsh lands in the major parts of plains 
of India (1) it is known to have anti tumour 
activity (2, 18). 
 
The plant has been prescribed for nervous 
disorders such s insanity, epilepsy, 
neurasthenia, nervous break down etc.  The 
fresh juice of the plant boiled in ghee may 
be given as such (brahmi oil).  It is also used 
as brain tonic (1). Isolation of alkaloids 
brahmine, hespestine, mannitol and saponins 
by the earlier workers (3-8). Sedative effect 
on dogs and frogs, tranquillizing effect and 
learning tests on albino rats have been 
reported by earlier workers (9-11). 
 
The present study evaluates the anti-cancer 
property of Bacopa monnieri (L) Penn. 
 
Materials and Methods 
 
Whole plants of Bacopa monnieri were 
collected from Kinathukkadavu, 20km. 
away from Coimbatore, Tamil Nadu and 
identified by Dr. Mohan, Botanical survey 
of India, Coimbatore with the help of 
herbarium sheets. 
 
Daltons lymphoma ascites tumor celkls 
(DLA) was obtained from amala cancer 
research centre, amala nagar trichur, kerala. 
 
All the chemicals used in the present stud of 
analytical reagent quality. 
 
Preparation of the drug 
 
The fresh samples of plant (whole plant) 
were collected, air dried and powdered.  The 
dried powder of the plant was cold extracted 
with 50% ethanol for seven days with 
occasional stirring. The process was 
repeated twice.  (12). The pooled extracts 
were concentrated, evaporated to dryness 
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under reduced pressure.  The extract was 
resuspended in1% gum acacia and subjected 
to the various studies. 
 
Determination of cytotoxicity 
 
Short term in vitro cytotoxicity assay was 
conducted using DLA tumour cells. 
100,200,400 µg of EEBM and 0.1ml of 1% 
gum acacia (control) were incubated at 37oC 
with one million cells in 1ml PBS 
(Phonsphate Buffer Saline) for three hours.  
(13, 17) after incubation, he percentage dead 
cell as determined using tryptan bluce 
exclusion method. 
 
Tumour reduction experiment 
 
Swiss albino mice weighing 17 to 25 gm 
supplied from our animal hous, J.S.S 
College of Pharmacy, Ooty, were housed in 
well ventilated cages and fed with normal 
mouse pellet feed (Lipton India) and water 
ad libitum were used for the study. DLA 
was propagated into the peritoneal cavity of 
the mice by injecting one million cells.  Te 
cells ere aspirated form developed tumour 
and washed with PBS.  The solid tumours 
developed in mice by injected one million 
cells subcutaneously on hind limbs.  The 
animals were divided into three groups. 
Each group was further subdivided in to two 
groups (Group a & b) were treated with 100, 
200 mg/kg body wt of EEM respectively.  
 
Group 1 animals were treated 24 hours after 
tumour transplantation once daily for 10 
days.  
 
Group 2 animals were treated once daily for 
10 days prior to tumous transplantation  
 
Group 4 animals were served as control 
treated with gum acacia (1%). 
 
Solid tumours were measured form day 7
th, 
14
th, 21
st, 28
th of transplantation.  Te volume 
was calculated using the formula V= 4/3π r1
2 
r2
2.  where r1
2 r2
2  are radii of tumours. (14) 
 
Haematological studies. 
 
In order to detect the influence of the EEBM 
on the hematological status of DLA bearing 
mice a comparison was made amongst the 
above mentioned four groups of mice on the 
14
th day after transplantation with normal 
mice. Blood was drawn from each mouse in 
the conventional way and white blood cells 
count (WBC), red blood cells count (RBC), 
differential count and hemoglobin (Hb) 
percentage were estimated. (15) 
 
Results 
 
Short term in vitro cytotoxicity assay 
 
The EEBM prepared was checked for their 
cytotoxicity by in vitro short term incubation 
with tumour cells (table 1) there was a dose 
dependent cytotoxicity to DLA tumour cells 
in vitro.  The cytotoxicity was found to be 
150µg/ml in vitro to these cells. It was found 
that treatment with 400 µg/ml produced a 
70% death of DLA cells. 
 
Tumour Reduction experiment 
 
The effect of EEBM on tumour reduction is 
son in (Table 2).  Administration of EEBM 
reduced solid tumour volume in mice 
considerable.  The maximum anti- tumour 
activity was shown in post treatment with 
200mg/kg body wt for 10 days once daily 24 
hrs after tumour transplantation group. 
 
For example, tumour volume of untreated 
mice was 0.19ml on 7
th day, 1.9ml on the 
28
th while for the treated mice the tumour 
volume was nil on the 7
th as ell as on the 
14
th day, 0.54 ml on the 21
st day and 1.8ml 
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on the 28
th day.  These data indicate a 
considerable reduction in tumour volume 
during the post treatment with 200mg/kg for 
10 days 24hrs after tumour transplantation. 
 
Haematological Parameters 
 
Haematological Parameters (table 3), of 
tumour bearing mice on day 14 were found 
to be significantly altered from the normal 
group.  The total WBC count was found to 
be increase. In a differential count of WBC, 
the percent of neutrophils increased wile the 
lymphocyte count decreased. At the same 
time interval, EEBM (200mg/kg/da/oral) 
treatment for 10 days after tumour 
transplantation could restore those altered 
parameters near to normal. 
 
Discussion and Conclusion  
 
The use of chemotherapeutical drugs in 
cancer therapy involves the risk of life 
threatening host toxicity. Therefore the 
research goes on to develop the drugs which 
selectively act on tumour cells. The plant 
Bacopa Monnieri belonging to the family 
scophulariaceae have high medicinal 
properties.  The present study also revealed 
its potential cytotoxic and anti-tumour 
properties. The EEBM has shown significant 
cytotoxicity assay was found to have 
significant cytotoxicity towards transformed 
cell lines.  In solid tumour reduction studies 
the treatment of EEBM exhibited significant 
tumour reducing property analysis of the 
haemotological parameters at 14 days after 
transplantation of EEBM treated groups 
were able to reverse the changes in the 
haematological parameters consequent to 
tumour transplantation. The possible 
mechanism of anti-tumour action of EEBM 
against DLA cells may be due to 
radiomimetic, nucleotoxic and cytotoxic 
effect and acts in a manner similar to that of 
a spindle poison and inhibits cell mitosis. 
(16, 17). 
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Table No. 1 
Short term in Vitro Cytotoxicity of EEBM 
 
Treatment µg/ml  Percentage Cell Death 
100 25% 
200 60% 
400 70% 
Control (0.1 ml 1 % Gum acacia)  7% 
 
Table No. 2 
Effect of EEBM on Solid Tumour Model 
 
Tumour Volume In Cubin Centimetre  Group  
Treatment 
Mg/kg 
7
th Day  14
th Day  21
st Day  28
th Day 
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----  -----  0.66 ± 0.09**  2.4 ± 0.20***  Gr. Ia 100 
Gr. Ib 200  ----  -----  0.54 ± 0.04 ***  1.82 ± 0.10*** 
Not determined  1.22 ± 0.09***  1.94 ± 0.07***  3.48 ± 0.07 ***  Gr. IIa 100 
Gr. IIb 200  Not determined  1.08 ± 0.07***  1.56 ± 0.07 ***  3.00 ± 0.08*** 
-----  1.50 ± 0.2*  3.29 ± 0.2*  6.6 ± 0.25  Gr. IIIa 100 
Gr. IIIb 200  -----  1.6 ± 0.12*  2.96 ± 0.2 *  6.4 ± 0.35* 
Gr. IV 
1%Gum 
Acacia 
0.19 ± 0.02  1.90 ± 0.29  3.30 ± 0.35  6.70 ± 0.26 
 
Group I: Received treatment 24 hrs after Tumour Transplantation. 
Group II: Received treatment 10 days after Tumour Transplantation. 
Group III: Received treatment 10 days prior to Tumour Transplantation. 
Values are the mean ± S.E.M. of six animal in group. 
Group I, II, III were compared with IV Group. 
Values marked with *, **, ***, indicate the significance (P<0.5, p<0.01, P<0.001, respectively). 
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Table No.3 
Effect of EEBM on Haematological Parameters 
 
Differential Count (%)  Group & 
Treatment 
Total EBS 
cells/ml x 10
6 
Total RBC 
cells/ml x 10
10 
Hb (g%) 
  Lymphocyte Neutrophil  Monocyte 
Normal 
Gr. I 100 mg/kg 
Gr. I 200 mg/kg 
Gr. II 100 mg/kg 
Gr. II 200 mg/kg 
Gr. III 100 mg/kg 
Gr. III 200 mg/kg 
Gr. IV1% Gum 
Acacia 
12.7 ± 0.76 
23.3 ± 0.97 * 
21.1 ± 0.53 ** 
21.3 ± 0.04 ** 
18.7 ± 0.48 *** 
26.7 ± 0.92* 
25.3 ± 1.22* 
27.0 ± 1.51 *** 
8.81 ± 0.52 
8.46 ± 0.53 * 
8.7 ± 0.49 * 
8.96 ± 0.46 * 
9.15 ±0.25 * 
9.1 ± 0.56 * 
8.85 ± 0.66* 
8.43 ± 0.5* 
 
13.6 ± 1.3 
12.9 ± 0.43* 
13.4 ± 0.62* 
12.6 ± 0.51* 
12.4 ± 0.5 * 
13.9 ± 0.36* 
13.4 ± 0.33* 
13.1 ± 0.47* 
65.8 ± 1.67 
47 ± 1.02*** 
50 ± 20.1*** 
42 ± 1.79** 
47 ± 1.55*** 
38.7 ± 2.7* 
31.9 ± 1.9* 
36 ± 1.29 *** 
32 ± 1.51 
50 ± 1.76 *** 
46 ± 1.28 *** 
53 ± 1.59*** 
51 ± 1.17 *** 
60 ± 1.8* 
65.5 ± 2.9* 
62 ± 1.68 *** 
2± 0.17 
3.1 ± 0.42* 
3.9 ± 0.31* 
4.1 ± 0.51* 
2.2 ± 0.31* 
2.1 ± 0.1* 
3.2 ± 0.4* 
2.1 ± 0.2* 
 
Group I: Received treatment 24 hrs after Tumour Transplantation. 
Group II: Received treatment 10 days after Tumour Transplantation. 
Group III: Received treatment 10 days prior to Tumour Transplantation. 
 Normal, Group 1, 2 and 3 compared with Group 4 
Values marked with *, **, ***, indicate the significance (P<0.5, p<0.01, P<0.001, respectively). 
Values are the mean ± S.E.M. of six animal in group. 
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